A management perspective on pharmaceuticals and personal care products (PPCPs) in Canadian urban waters is presented. The issues of PPCPs occurrence, effects, and means of control have been studied intensively during the past 10 years, but the information available is not yet sufficient to develop risk assessment/management strategies at this time. The management strategies receiving most attention include PPCP emission controls by pharmaceutical return programs, education of medical professionals to reduce prescription rates, incentives for green drug manufacturing, improving treatment technologies for drinking water and wastewaters, and introducing risk assessment regulations. Further research is needed on both effects and risk mitigation by the above listed measures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boyd, G.R., Reemtsma, H., Grimm, D.A., Mitra, S. 2003. Pharmaceuticals and personal care products (PPCPs) ins surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 311, 135-149.
Canadian Environmental Protection Act 1999. 2000. Government of Canada, Ottawa, Ontario.
Citulski, J., Farahbakhsh, K. 2007. Assessing the efficacy of immersed ultrafiltration membranes in removing phosphorus and endocrine disrupting compounds during tertiary wastewater treatment, with implications for water reuse. In: Abstracts, 42nd Central Canadian Symposium on Water Quality Research, Burlington, Ont., Feb. 12-13, 2007.
Crane, M., Watts, C., Boucard, T. 2006. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci. of Tot. Environ 367, 23-41.
Daughton, C.G., Ternes, T.A. 1999. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspectives 107, 907-938.
Daughton, C.G. 2004a. Groundwater recharge and chemical contaminants: challenges in communicating the connections and collisions of two disparate worlds. Ground Water Monitoring & Remediation 24(2), 127-138.
Daughton, C.G. 2004b. PPCPs in the environment: future research - beginning with the end always in mind. In: K. Kummerer (ed.), Pharmaceuticals in the Environment, 2nd edition, Springer-Verlag, Heidelberg, 463-495.
Doerr-MacEwen, N., Haight, M. 2006. Expert Stakeholders’ Views on the Management of Human Pharmaceuticals in the Environment. Environmental Management 38(5), 853-866.
Flaherty, C.M., Dodson, S.I. 2005. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 61, 200-207.
Government of British Columbia. 1997. Waste Management Act: Post-consumer residual stewardship program regulation. B.C. Reg. 111/97, O.C. 333/97, Victoria, BC.
Halling-Sorenson, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, F., Holten-Lutzhof, H.C., Jorgensen, S.E. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment: a review. Chemosphere 36, 357-391.
Health Canada. 2003. Environmental assessment regulations: final issue identification paper. http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hpfb-dgpsa/pdf/contaminants/final_iip-dde_e.pdf (visited March 15, 2007).
Heberer, T. 2002a. Occurrence, fate and assessment of polycyclic musk residues in the aquatic environment of urban areas - a review. Acta Hydrochim. Hydrobiol. 30, 227-243.
Heberer, T. 2002b. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 266, 175-189.
Holtz, S. 2006. There is no “away”. Pharmaceuticals, Personal care products, and endocrine disrupting substances: emerging contaminants detected in water. Canadian Institute for Law and Environmental Policy, Toronto, Ontario.
Hua, W., Bennett, E.R., Letcher, R.J. 2006. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Research 40, 2259-2266.
Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thirman, E.M., Zaugg, S.D., Barber, L.B., Buxton, H.T. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 36, 1202-1211.
Kummerer, K. (ed.). 2004a. Pharmaceuticals in the environment: source, fate, effects and risks. Springer-Verlag, Heidelberg.
Kummerer, K. (ed.). 2004b. Emissions from medical care units. In: K. Kummerer (ed.), Pharmaceuticals in the environment: source, fate, effects and risks. Springer-Verlag, Heidelberg.
Lishman, L., Smyth, S.A., Sarafin, K., Kleywegt, S., Toito, J., Peart, T., Lee, B., Servos, M., Beland, M., Seto, P. 2006. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Science of Tot. Env. 367 (2-3), 544-558.
Lishman, L., Parker, W., Seaman, L., Sharif, R., Kennedy, K., Yang, J.J., Svoboda, L. 2007. Fate of synthetic musks during aerobic digestion of municipal wastewater treatment sludge. In: Abstracts, 42nd Central Canadian Symposium on Water Quality Research, Burlington, Ont., Feb. 12-13, 2007.
Luckenbach T., Epel D. 2005. Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defense systems mediated by multi-drug transporters. Environ Health Perspect 113, 17-24.
Makdissy, G., Peldszuz, S., McPhail, R., Huck, P. 2007. Rejection of endocrine disrupting compounds, pharmaceuticals and personal care products using tight and loose nanofiltration membranes. In: Abstracts, 42nd Central Canadian Symposium on Water Quality Research, Burlington, Ont., Feb. 12-13, 2007.
Marsalek, J., Barnwell, T.O., Geiger, W.F., Grottker, M., Huber, W.C., Saul, A.J., Schilling, W., and Torno, H.C. 1993. Urban drainage systems: design and operation, Wat. Sci. Tech. 27(12), 31-70.
Metcalfe, C.D., Koenig, B.G., Bennie, D.T., Servos, M., Ternes, T.A., Hirsch, R. 2003. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environmental Toxicology and Chemistry 22(12), 2872-2880.
Metcalfe, C.D., Miao, X.S., Koenig, B.G., Struger, J., Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. 2003. Environmental Toxicology and Chemistry 22(12), 2881-2889.
Metcalfe, C.D., Miao, X.S., Hua, W., Letcher, R., Servos, M. 2004. Pharmaceuticals in the Canadian Environment. In: K. Kümmerer (Ed.), Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, Second Edition, Springer-Verlag, Heidelberg, 67-87.
Moffat, A.C., Osselton, M.D., Widdop, B. 2004. Clarke’s analysis of drugs and poisons. Pharmaceutical Press, London, UK.
Parrot, J. 2006. Pharmaceuticals and personal care products in the Canadian environment. Environment Canada Workshop on The effects of pharmaceuticals and personal care products in the environment. A PowerPoint presentation at the workshop, Sept.
Parrott JL, Blunt BR. 2005. Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization success and demasculinizes males. Environ. Toxicol. 20(2), 131-141.
Parrot, J., Blunt, B., Sullivan, C., Bennie, D. 2007. Fathead minnow lifecycle exposure to a mixture of seven pharmaceuticals. In: Abstracts, 42nd Central Canadian Symposium on Water Quality Research, Burlington, Ont., Feb. 12-13, 2007.
Schwab, B.W., Hayes, E.P., Fiori, J.M., Mastrocco, F.J., Roden, N.M., Cragin, D., Meyerhoff, R., D’Aco, V.J., Anderson, P.D., 2005. Human pharmaceuticals in U.S. surface water: A human health risk assessment, Regulatory Toxicology and Pharmacology 42, 296-312.
Servos, M. 2007. Progress in exposure assessment of pharmaceuticals and personal care products in the Canadian Environment: how far have we travelled since 2002? Presentation at the Environment Canada workshop on Pharmaceuticals and personal care products in the Canadian Environment: research and policy directions. Niagara on the Lake, Ont., March 5-7, 2007.
Servos, M., Bennie, D.T., Starodub, M.E., Orr, J.C. 2002a. Pharmaceuticals and personal care products in the environment: a summary of published literature. National Water Research Institute, Environment Canada, Report No. 02-309, Burlington, Ontario.
Servos, M.R., Innes, E., Given, J., Ostapyk, K., Topp, E., McInnis, R., Starodub, M.E. (eds.). 2002b. Assessment and management of pharmaceuticals and personal care products in the Canadian environment: Proceedings of a multi-stakeholder workshop. Environment and Health Canada Special publication, Ottawa, Ontario.
Servos, M.R., Bennie, D.T., Burnison, B.K., Jurkovic, A., McInnis, R., Neheli, T., Schnell, A., Seto, P., Smyth, S.A., Ternes, T.A. 2005. Distribution of estrogens, 17b-estradiol and estrone, in Canadian municipal wastewater treatment plants. Sci. Tot. Environ. 336, 155-170.
Smyth, S.A., Lishman, L., McBean, E., Kleywegt, S., Yang, J., Svoboda, L., Lee, H., Seto, P. 2007. Seasonal occurrence and removal of synthetic musks from Grand River wastewater treatment plants. In: Abstracts, 42nd Central Canadian Symposium on Water Quality Research, Burlington, Ont., Feb. 12-13, 2007.
Sosiak, A., Hebben, T. 2005. A preliminary survey of pharmaceuticals and endocrine disrupting compounds in treated municipal wastewaters and receiving rivers of Alberta. Alberta Environment, Edmonton.
Ternes, T.A., and Joss, A. (eds). 2006. Human pharmaceuticals, hormones and fragrances: The challenge of micropollutants in urban water management. IWA Publishing, London, UK.
Ternes, T.A., Stumpf, M., Muller, J., Haberer, K., Wilken, R.-D., Servos, M. 1999. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Sci. Tot. Environ 225(1), 81-90.
Webb S., Ternes, T.A., Gibert, M., Olejniczak, K. 2003. Indirect human exposure to pharmaceuticals via drinking water. Toxicol. Lett. 142, 157-167.
Yang, J.J., Metcalfe, C.D. 2006. Fate of synthetic musks in a domestic wastewater treatment plant and in an agricultural field amended with biosolids. Sci. of Tot. Environ. 363 (1-3), 149-65.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this paper
Cite this paper
Marsalek, J. (2008). Pharmaceuticals And Personal Care Products (Ppcp) In Canadian Urban Waters: A Management Perspective. In: Hlavinek, P., Bonacci, O., Marsalek, J., Mahrikova, I. (eds) Dangerous Pollutants (Xenobiotics) in Urban Water Cycle. NATO Science for Peace and Security Series. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6795-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6795-2_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6800-3
Online ISBN: 978-1-4020-6795-2
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)